|
ACAD8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62458935193399E-12 |
| Normal-vs-Stage2 |
3.50550000138838E-09 |
| Normal-vs-Stage3 |
1.11022302462516E-16 |
| Normal-vs-Stage4 |
4.46309655899313E-14 |
| Stage1-vs-Stage2 |
9.782600E-01 |
| Stage1-vs-Stage3 |
1.003300E-04 |
| Stage1-vs-Stage4 |
8.89369999979017E-07 |
| Stage2-vs-Stage3 |
4.999500E-03 |
| Stage2-vs-Stage4 |
8.01780000000418E-05 |
| Stage3-vs-Stage4 |
9.109800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.6242562850266E-12 |
| Normal-vs-AfricanAmerican |
5.88418203051333E-15 |
| Normal-vs-Asian |
6.96699999913619E-08 |
| Caucasian-vs-AfricanAmerican |
7.646400E-01 |
| Caucasian-vs-Asian |
2.044000E-01 |
| AfricanAmerican-vs-Asian |
2.280800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.6242562850266E-12 |
| Normal-vs-Female |
1.75648384725946E-12 |
| Male-vs-Female |
9.805800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.64990243689545E-12 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
<1E-12 |
| Normal-vs-Extreme_Obese |
3.026200E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.154000E-01 |
| Normal_Weight-vs-Obese |
8.045800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.133900E-02 |
| Extreme_Weight-vs-Obese |
7.767200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.062800E-01 |
| Obese-vs-Extreme_Obese |
9.219800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.06049954876164E-10 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
9.99200722162641E-16 |
| Normal-vs-Age(81-100Yrs) |
2.07900000548378E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.308800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.551400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.137800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.102000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.917800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.651200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
4.44089209850063E-15 |
| Normal-VS-KIRP CIMP |
1.70974345792274E-12 |
| Normal-VS-Unclassified PRCC |
1.04939945622107E-10 |
| Type1 PRCC-VS-Type2 PRCC |
2.356400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.52079999996102E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
7.957400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.52089999999605E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
5.739000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.52723999999882E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.55431223447522E-15 |
| Normal-vs-N1 |
<1E-12 |
| Normal-vs-N2 |
6.74139999379264E-09 |
| N0-vs-N1 |
1.45730000000732E-06 |
| N0-vs-N2 |
1.163580E-02 |
| N1-vs-N2 |
2.082000E-01 |
|
|
